Vabiotech COVID-19 vaccine

Vabiotech COVID-19 vaccine
Vaccine description
TargetSARS-CoV-2
Vaccine typeProtein subunit
Clinical data
Routes of
administration
Intramuscular

Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam.[1]

Clinical trials

Preclinical

In May 2020, Vietnam declared that their COVID-19 vaccine was developed after scientists successfully generated the novel coronavirus antigen in the lab. The vaccine has been developed by collaborating scientists at VABIOTECH in Hanoi and the Bristol University, it will be tested further in animals and evaluated for safety and effectiveness before a manufacturing process is embarked on. According to the National Institute of Hygiene and Epidemiology, it will take at least 12–18 months to develop vaccine that can work safely on human.[2][3] During the testing phase, researchers experimented by injecting the mice in many ways and administering multiple antigen doses, with some mice injected with one or two doses of 3-10 micrograms each. After 10 days, 50 mice were in good health and being closely monitored for immune responses. After gaining positive results with immune response and antibody production, the trial vaccine would be developed into a complete and stable version qualified to be used on humans. The research team would also develop commercial production procedures for mass-production, including up to tens of millions of units.[4][5]

In October 2020, the vaccine has been tested on 12 rhesus macaques (Macaca mulatta) in an island off the northern Quang Ninh province.[6] The macaques are aged 3–5, weighing more than three kilograms each, and not infected with contagious diseases like tuberculosis or the HIV virus. Before being injected with the vaccine, they had their body temperatures, blood and swab samples taken and were kept separately in cages. They will be tested in two periods. In each period, they will be divided into two groups, with one being vaccinated and the other not. After that, they will be monitored daily on separate islands, before their blood samples are taken for further analysis. The testing will follow a similar model that maybe later performed on humans. The animals will be injected two shots of the vaccine, 18 to 21 days apart. A month after the second shot, researchers will assess the monkeys' immune response to see the difference between the injected group and the non-injected group.[7] The result of these trials will be presented before the health ministry's ethical board within the following four months if experiments show the vaccine does produce effective immunogenicity and provide effective protection against COVID-19. It will be a foundation for the next stage for testing the vaccine on humans.[8][9]

References

  1. ^ "Dự kiến cuối quý 3-2021, Việt Nam sẽ có vaccine phòng Covid-19 đầu tiên" [It is expected that at the end of the third quarter of 2021, Vietnam will have the first Covid-19 vaccine] (in Vietnamese). Nhân Dân. 22 March 2021. Retrieved 25 March 2021.
  2. ^ "Việt Nam thử nghiệm vaccine Covid-19 trên chuột" [Vietnam new COVID-19 vaccine was developed]. VnExpress (in Vietnamese). 3 May 2020.
  3. ^ "Việt Nam tập trung nghiên cứu, sản xuất vaccine phòng, chống COVID-19" [Vietnam focuses on research and production of vaccines against COVID-19]. Ministry of Health (Vietnam) (in Vietnamese). 29 April 2020. Archived from the original on 15 May 2020.
  4. ^ "Thử nghiệm bước đầu thành công vaccine Covid-19 Việt Nam" [Successful initial trial of Covid-19 vaccine in Vietnam]. VnExpress (in Vietnamese). 7 May 2020.
  5. ^ "Vaccine Covid-19 của Việt Nam sinh miễn dịch cao" [Vietnam's Covid-19 vaccine produces high immunity]. VnExpress (in Vietnamese). 26 June 2020.
  6. ^ "Kỳ vọng vắc xin Covid-19 Việt Nam" [Expectations for a Covid-19 vaccine in Vietnam]. Thanh Niên (in Vietnamese). 4 November 2020.{{cite news}}: CS1 maint: url-status (link)
  7. ^ "Việt Nam tests COVID-19 vaccine on monkeys". VietNamNews. 2 November 2020.{{cite news}}: CS1 maint: url-status (link)
  8. ^ "Việt Nam thử nghiệm vaccine Covid-19 trên khỉ" [Vietnam tests Covid-19 vaccine on monkeys]. Nhân Dân (in Vietnamese). 30 October 2020.{{cite news}}: CS1 maint: url-status (link)
  9. ^ Le C (31 October 2020). "Vietnam begins Covid-19 vaccine trials on monkeys". VnExpress.{{cite news}}: CS1 maint: url-status (link)

Media files used on this page

Coronavirus. SARS-CoV-2.png
Author/Creator: Alexey Solodovnikov (Idea, Producer, CG, Editor), Valeria Arkhipova (Scientific Сonsultant), Licence: CC BY-SA 4.0
Scientifically accurate atomic model of the external structure of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), a strain (genetic variant) of the coronavirus that caused Coronavirus disease (COVID-19), first identified in Wuhan, China, during December 2019

Each separate locus (amorphous blob) is an atom of:

  cobalt: membrane
  crimson: E protein
  green: M protein
  orange: glucose (glycan)
  turquoise : S (spike) glycoprotein
SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors
Scholia logo.svg
Author/Creator: Lars Willighagen, Licence: CC BY-SA 4.0
SVG remake of proposal for Scholia logo (File:Scholia logo.png by User:Theklan).
WHO Rod.svg
The rod of Asclepius as depicted in the WHO logo.
Sida-aids.png
Author/Creator: User:FoeNyx © 2004 (artistic illustration), Licence: CC-BY-SA-3.0
VIH - HIV / SIDA - AIDS viruses.
COVID-19 Pandemic Cases in Vietnam.svg
Author/Creator: Nguyễn Quốc Trung, Lâm Đức Anh, Thanh2k2, Night Lantern and BeeBeeSPC., Licence: CC BY-SA 4.0
English (en): Map of the COVID-19 pandemic in Vietnam as of 3 Mar 2022. Be aware that since this is a rapidly evolving situation, new cases may not be immediately represented visually. Refer to the primary article 2019–20 outbreak of novel coronavirus 2019-nCoV or the World Health Organization's situation reports for most recent reported case information.
  Confirmed 1–49,999
  Confirmed 50,000–99,999
  Confirmed 100,000–199,999
  Confirmed 200,000–499,999
  Confirmed ≥ 500,000